Sign In
Buy ARKG
$33.15
-0.260 (-0.778%)
At Close: Jun 08, 2026
Innovation Is Crucial to Healthcare Sector Long-Term Growth
12:31pm, Thursday, 23'rd Mar 2023
Experienced healthcare investors know several important facts regarding large-cap, blue-chip biopharma companies. First, these firms enjoy a limited amount of time when their blockbuster drugs corner
Stocks that are cyclical are going to face severe challenges, says ARK Invest's Cathie Wood
11:52am, Tuesday, 21'st Mar 2023
Cathie Wood of ARK Invest joins 'Squawk on the Street' to discuss her thoughts on the tech space, banking crisis and more.
Outlook for Healthcare Innovation Is Brightening
09:52am, Friday, 17'th Mar 2023
Healthcare is an epicenter of innovation, and some exchange traded funds put investors front and center when it comes to accessing that theme. Count the ARK Genomic Revolution ETF (ARKG) as one of the
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
11:31am, Wednesday, 15'th Mar 2023
Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance.
These Segments Could Power ARK Genomics ETF
08:32am, Friday, 24'th Feb 2023
Genomics is one of the epicenters of healthcare innovation and that will remain true for years to come. For investors looking to tap into that theme, it pays to examine some of the catalysts that will
Bright Future for this Disruptive Healthcare ETF
09:53am, Tuesday, 21'st Feb 2023
The healthcare sector has long been a mecca of innovation and one of the key elements in that theme is the evolution of genetics. Not only does that profound effects on patient outcomes, but there are
Eye DNA Synthesis Advances in Active Biotech ETF ARKG
02:38pm, Wednesday, 01'st Feb 2023
It's hard to imagine it now, but at the turn of the millennium, the big advancement in technology was not the latest phone app, it was the Human Genome Project. Since then, genetics advancements are n
Get Benefits From Innovator ACCD in Health Tech ETF ARKG
01:06pm, Wednesday, 18'th Jan 2023
For all the concerns surrounding tech investments over the last year, with mega-cap tech names like Amazon (AMZN) and Meta (META) being the poster children for the broad market selloff, biotech remain
Best ETF Areas of Last Week
02:18pm, Tuesday, 17'th Jan 2023
Wall Street was pretty upbeat last week due to cooling inflation.
Can Health Care Stocks Outperform Again In 2023?
06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
EXAS Nears Key Buy Signal in Active Biotech ETF ARKG
05:11pm, Wednesday, 11'th Jan 2023
There are a lot of reasons to be skeptical of tech investing right now since last year's broad market selloff — just how far is the Fed planning to go with rising rates this year, anyway? Still, the
ARKG: Despite A Huge Price Loss In 2022, Not The Right Time To Accumulate
01:22pm, Wednesday, 04'th Jan 2023
ARK Genomic Revolution ETF invests in small-cap and mid-cap companies engaged in genomic revolution, i.e., in the research of genomic sequencing, analysis, synthesis, or instrumentation. Alpha-generat
ARKG: Market May Ridicule ARK, But You Shouldn't Ignore Their Genomics ETF
03:17pm, Tuesday, 03'rd Jan 2023
ARK Invest does great deep-dive research. Utilize their insights along with market timing considerations to generate alpha. The performance of ARKG is dictated mostly by interest rate decisions in the
Why Now Could Be Time to Buy No Cap Gain ARK Strats
02:07pm, Friday, 30'th Dec 2022
Ready for the new year? It wouldn't be surprising for most ETF investors to be excited to put 2022 in the rear view.
Top-Read Disruptive Technology Stories of 2022
03:44pm, Monday, 26'th Dec 2022
2022 has been a wild year for markets, from Russia's invasion of Ukraine to the Fed's dedicated rate hike campaign. That hasn't stopped the world from innovating, though, with firms in areas from biot
